Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-07 4:17 pm |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer |
90,000 | $8.8018 | $792,160 | 32,606 (Direct) |
View |
| 2024-11-21 Sale |
2024-11-22 4:38 pm |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
13,665 | $8.4 | $114,786 | 0 (Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 4:17 pm |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
43,657 | $8.61 | $375,887 | 13,665 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Tax Withholding |
2025-03-05 8:21 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer |
15,579 | $8.84 | 620,440 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 8:21 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer |
291,096 | $0 | 620,440 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-05 8:21 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer |
49,145 | $8.76 | 620,440 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 8:21 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer |
187,330 | $0 | 620,440 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:54 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
430,557 | $0 | 647,848 (Direct) |
View |
| 2024-03-03 Exercise |
2024-03-05 4:54 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
60,871 | $0 | 647,848 (Direct) |
View |
| 2024-03-03 Tax Withholding |
2024-03-05 4:54 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
18,030 | $5.47 | 647,848 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
458,715 | $0 | 541,131 (Direct) |
View |
| 2023-03-03 Tax Withholding |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
8,164 | $1.92 | 541,131 (Direct) |
View |
| 2023-03-03 Exercise |
2023-03-07 6:00 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
22,645 | $0 | 541,131 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-03 9:18 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
271,740 | $0 | 271,740 (Direct) |
View |
Ownership |
2022-01-26 7:38 pm |
N/A N/A |
Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer |
0 | $0 | 0 (Direct) |
View |